Perivascular aquaporins: potential postischemic therapeutic drug targets?
Fraser
Douglas D
DD
Andrew
R David
RD
D000818:Animals; D051401:Aquaporin 4 / Q000378:metabolism*; D001253:Astrocytes / Q000378:metabolism; D001929:Brain Edema / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D002545:Brain Ischemia / Q000150:complications; D002135:Calcium-Binding Proteins / Q000235:genetics; D008565:Membrane Proteins / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009124:Muscle Proteins / Q000235:genetics; D009995:Osmosis; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use*
D051401:Aquaporin 4; D002135:Calcium-Binding Proteins; D008565:Membrane Proteins; D009124:Muscle Proteins; D012462:Saline Solution, Hypertonic; C091825:syntrophin alpha1